Granulosa Cell Tumor - Clinical Group and Review of
Freitag P., Janoušek M., Jančárková N., Bendová M., Strunová M., Živný J.
Gynek.-porod. klinika 1. LF UK a VFN v Praze, přednosta prof. MUDr. J. Živný, DrSc. |
|
Abstract:
Objective: To present a review of literature and to analyse a clinical retrospective series of pa-
tients with granulosa cell tumor.
Design: Retrospective study and review.
Setting: Department of Obstetrics and Gynaecology, First Faculty of Medicine, Prague, Czech
Republic.
Methods: Retrospective analysis of age, stage, surgery, radiotherapy and chemotherapy, survival
curve, number of recurrences and time to recurrence. Literature and information database (Med-
line 1997-1999) review.
Results: In a group of 43 patients the median of age was 53.5 years. 83.7% of cases were in a stage I.
There were two duplicite tumors in a series. Conservative surgery was performed in 9/43 cases, 5
of them were reoperated on. The most frequent chemotherapy regimens were platinum-cyclo-
phoshamide and BEP (bleomycin, etoposide, platinum). The 5-year overall survival was 86% and
specific survival 90.7%. There were 3/43 recurrences, median time to recurrence was 22 months.
Conclusion: A good prognosis of a patient with granulosa cell tumor requires a precise histopa-
thologic examination, an adequate surgery and a comprehensive clinical analysis of a case to
evaluate an indication of adjuvant therapy. Concentration of patients in oncogynaecological cen-
tres is advisable. A careful follow-up because of a risk of late recurrences is necessary.
Key words:
granulosa cell tumor, ovary
|